| Title: |
The place of Ivabradine in management of chronic heart failure patient with implanted cardiac resynchronization therapy - case report |
| Authors: |
Marinova, Zhenya; Tsvetanova, Roksana; Ivanova, Elena; Hristov, Dimitar; Mircheva, Lilyana |
| Source: |
Scripta Scientifica Vox Studentium; Vol 2 (2018): Suppl.1. Abstracts of the Sixth Black Sea Symposium for Young Scientists in Biomedicine (BSYSB), April 12-15 2018, Varna; 78 ; 2535-048X ; 2535-0471 |
| Publisher Information: |
Medical University of Varna |
| Publication Year: |
2018 |
| Collection: |
Varna Medical University Press: Journals |
| Subject Terms: |
heart failure; CRT; Ivabradine; management |
| Description: |
Introduction: Heart failure is a syndrome characterized by typical symptoms (e.g. dyspnoea, pretibial oedema, fatigue) caused by structural and/or functional cardiac abnormalities, resulting in reduced cardiac output and/or elevated intracardiac pressures at rest or during stress. It is end-stage of all cardiovascular diseases and due to its wide spread may easily be described as an epidemic of 21st century.Materials and methods: We present a case of 52-year-old male with a history of coronary artery disease who underwent percutaneous coronary intervention due to chest pain with implantation of 2 drug-eluting stents. In 2016 after suffering anterior myocardial infarction he was hospitalized again and another PCI of stent thrombosis of the proximal LAD was performed. During the patient`s hospital stay an ejection fraction of 30% and left bundle branch block were established and he developed signs of total HF. The combination of low EF and LBBB lead to the implantation of CRT-D. On 03.2017 he was urgently admitted to II. Cardiology Clinic in UMHAT `St. Marina` with progressive symptoms of CHF. After a correction of therapy and optimization of the CRT-D under ultrasound control the patient had subjective improvement and reduction of swelling. Due to lack of adequate heart rate control after correction of CRT parameters and optimal dose of beta-blocker, Ivabradine was added to patients therapy.Results: The following check-ups showed significant improvement, no symptoms of exacerbated HF, no readmissions due to the condition and NYHA class II-III.Conclusion: Management of HF patients with CRT should follow the same algorithm as in all other HF patients. In cases of sinus rhythm and HR>70/min Ivabradine is a drug of choice for HR control which also improves physical capacity and quality of life. However, despite the availability of numerous therapy methods that increase the life expectancy of these patients, the prognosis remains poor. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.14748/ssvs.v2i0.4612 |
| Availability: |
https://journals.mu-varna.bg/index.php/ssvs/article/view/4612; https://doi.org/10.14748/ssvs.v2i0.4612 |
| Rights: |
Всички публикации наScripta Scientifica Vox Studentium са лицензирани под Creative Commons Attribution 3.0 License. ; All work by Scripta Scientifica Vox Studentium is licensed under a Creative Commons Attribution 3.0 License. |
| Accession Number: |
edsbas.9B73CE41 |
| Database: |
BASE |